Science
New Collaborative Cornell Research Finds SARS-CoV-2 can Infect and Deteriorate Dopamine Neurons
|
Weill Cornell researchers discover new insight into the effects of SARS-CoV-2 on the brain.
The Cornell Daily Sun (https://cornellsun.com/tag/neuroscience/)
Weill Cornell researchers discover new insight into the effects of SARS-CoV-2 on the brain.
Weill Cornell Medicine researchers gave new insights on the onset of Alzheimer’s disease and a cerebrovascular disorder known as cerebral amyloid angiopathy, identifying the mechanisms of the protein amyloid beta in an Oct. 3 study.
Medicine and artificial intelligence are ever-evolving fields at the forefront of scientific discovery. A new Cornell research group — Machine Learning in Medicine — aims to coalesce the two, with the goal of improving methods for disease detection and diagnosis. This endeavor is a collaboration between faculty at Cornell Tech and Weill Cornell Medicine, bringing together “researchers with common interests and complementary expertise.” MLIM’s work is primarily an interdisciplinary dialogue, bridging campuses and research fields.
“The idea was to link people with a machine learning background in Ithaca to [people working with] clinical data and hypotheses at Weill,” said Prof. Amy Kuceyeski, mathematics and radiology, one of the organizing members of the group. While Kuceyeski’s background is in mathematics, she started learning methods for modeling biological systems as a postdoctoral researcher at Weill. Seeing this as an area for innovation, Kuceyeski helped establish MLIM in 2018.
Five panelists — one each from the departments of biological engineering, industrial labor relations, neuroscience, history and philosophy — grappled with this question as they attempted to convince the Klarman Hall audience that their respective fields of study mattered most and should be preserved.